Emeis S.A (EMEIS) | Stock Overview & Key Data
Emeis S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €8,238.46 on February 17, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Emeis S.A
EMEIS
|
2.28B Large-cap | -2.97% | -9.31% | -2.28% | 4.65% | -6.09% | 35.08% | -91.30% | -99.79% | -99.68% | -99.55% | -99.55% |
|
Orpea
ORP
|
2.19B Large-cap | -3.09% | -8.72% | 7.30% | 7.30% | 7.30% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% |
|
Clariene SE
CLARI
|
1.36B Large-cap | -0.74% | -5.16% | 15.10% | 15.10% | 15.10% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% |
| 1.10B Large-cap | -0.44% | 8.74% | 7.18% | 24.44% | 19.91% | 1.34% | -43.25% | -42.39% | -9.42% | 37.08% | 37.08% | |
|
Lna Santé S.A
LNA
|
297.53M Mid-cap | -2.94% | 9.27% | 18.71% | 18.71% | 18.71% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
Ownership & Short Interest
Calculate Your Emeis S.A Investment Returns
Long-Term Investment Performance Analysis
Emeis S.A stock price in Jul 2016 was €5,109.76, A €1,000.00 lump sum investment in Emeis S.A made 9 years ago would be worth approximately €2.69 today, representing a negative return of -99.73%. This translates to an annualized return (CAGR) of -44.98%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EMEIS's 52-week high and low?
- In the last 52 weeks, Emeis S.A reached a high of €16.19 (on October 10, 2025) and a low of €9.94 (on June 26, 2025).
- What is the market cap and P/E ratio for EMEIS?
- Curious about Emeis S.A's size and valuation? Its market capitalization stands at 2.28B. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.02, and the forward P/E (looking ahead) is 153.96.
- Does EMEIS pay dividends? If so, what's the yield?
- As for dividends, Emeis S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Emeis S.A's main competitors or similar companies to consider before investing?
When looking at Emeis S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Orpea
ORP2.19B Healthcare Medical Care Facilities 12.35% 12.35% Clariene SE
CLARI1.36B Healthcare Medical Care Facilities 20.23% 20.23% Ramsay Générale de
GDS1.10B Healthcare Medical Care Facilities 1.34% -43.25% Lna Santé S.A
LNA297.53M Healthcare Medical Care Facilities 26.14% 26.14% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Emeis S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Emeis S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -19.04%, the Debt to Equity ratio from the most recent quarter is 598.44, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EMEIS?
- Looking at Emeis S.A's growth, its revenue over the trailing twelve months (TTM) was €6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of EMEIS stock is held by insiders and institutions?
- Wondering who owns Emeis S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 60.14%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.